Core Viewpoint - The company plans to utilize idle funds for entrusted wealth management and securities investment, with a total amount not exceeding RMB 2.9 billion, to enhance the efficiency of fund usage and generate returns for shareholders [2][3][14]. Investment Overview - Investment Purpose: The company aims to improve the efficiency of idle funds while ensuring normal business operations and daily capital needs [3]. - Total Investment Amount: The total investment amount will not exceed RMB 2.9 billion, with RMB 2.3 billion allocated for entrusted wealth management and RMB 600 million for securities investment [2][3][14]. - Investment Duration: The investment period is set for 12 months from the approval date of the board meeting [4][14]. Investment Details - Source of Funds: The funds will come from the company's idle self-owned capital [4]. - Investment Methods: Entrusted wealth management will focus on bank wealth management products, income certificates, and funds, while securities investment will include government bonds, bond repurchase agreements, ETFs, and stocks [4][3]. - Approval Process: The investment plan has been approved by the company's board of directors and does not require shareholder meeting approval [6][14]. Impact on the Company - The use of idle funds for wealth management and securities investment will not affect the company's normal cash flow or operations, and it aims to enhance fund returns and protect shareholder interests [8][14]. - Accounting Treatment: The company will account for the entrusted wealth management and securities investment in accordance with relevant accounting standards, reflecting them in the balance sheet and income statement [8].

Core Viewpoint - Chenxin Pharmaceutical (603367) announced plans to utilize idle funds for entrusted wealth management and securities investment, with a total amount not exceeding 2.9 billion yuan, aiming to enhance the efficiency of fund usage and generate higher returns for shareholders [1] Group 1: Investment Plans - The company and its subsidiaries plan to use idle self-owned funds for entrusted wealth management and securities investment, with a total limit of 2.9 billion yuan, including up to 2.3 billion yuan for entrusted wealth management and up to 600 million yuan for securities investment [1] - The investment aims to improve the efficiency of idle funds while ensuring that the company's main business operations and daily capital needs are not affected [1] Group 2: Investment Types - Entrusted wealth management will primarily involve bank wealth management products, income certificates, and funds from financial institutions [1] - Securities investment will focus on government bonds or reverse repos, bonds, ETFs, stocks, and other investments permitted by laws and regulations [1]

Core Viewpoint - The company announced plans to utilize idle self-owned funds for entrusted wealth management and securities investment, with a total amount not exceeding 2.9 billion yuan [1] Group 1: Financial Allocation - The total amount for entrusted wealth management is capped at 2.3 billion yuan [1] - The total amount for securities investment is capped at 600 million yuan [1] - The duration for utilizing these funds is set for 12 months from the date of board approval [1]

格隆汇1月5日丨辰欣药业(603367.SH)公布，公司及控股子公司拟使用闲置自有资金进行委托理财及证 券投资，合计额度不超过人民币29亿元（含），其中委托理财的额度不超过人民币23亿元（含），证券 投资的额度不超过人民币6亿元（含）。资金额度使用期限为自本次董事会审议通过本议案之日起12个 月。 ...

格隆汇1月5日丨辰欣药业(603367.SH)公布，公司及控股子公司拟使用闲置自有资金进行委托理财及证 券投资，合计额度不超过人民币29亿元（含），其中委托理财的额度不超过人民币23亿元（含），证券 投资的额度不超过人民币6亿元（含）。资金额度使用期限为自本次董事会审议通过本议案之日起12个 月。 ...

Group 1 - The company has approved the use of up to RMB 450 million of its own funds for low-risk, high-liquidity financial products as of December 26, 2025 [2] - As of the announcement date, the company has invested RMB 208.007 million in various financial products from multiple financial institutions [2] - The total amount of funds used for entrusted wealth management is RMB 175 million, accounting for 16.78% of the company's latest audited net assets [4] Group 2 - The company emphasizes that the entrusted wealth management will not significantly impact its main business, financial status, or cash flow [4] - The company has implemented several risk control measures, including board authorization for investment decisions and regular audits of fund usage [5] - The company has confirmed that there are no undisclosed significant matters affecting its stock price or operations [14][17]

Core Viewpoint - The company has approved a plan to use idle funds for entrusted wealth management in 2026, with a total investment limit of RMB 600 million, aimed at improving fund efficiency and increasing investment returns for shareholders [7][8][18]. Group 1: Board Meeting Details - The ninth board meeting of the company was held on December 30, 2025, with all 9 directors present, making the meeting valid according to legal and company regulations [2]. - The board reviewed and approved the proposal for using idle funds for wealth management [3][4]. Group 2: Wealth Management Plan - The company plans to invest in low-risk financial products, including principal-protected wealth management products and government bond reverse repos, with a risk level not exceeding R3 [7][8]. - The total amount allocated for entrusted wealth management is RMB 600 million, which can be rolled over within the specified limit [9]. - The authorized period for this investment is from January 1, 2026, to December 31, 2026 [10]. Group 3: Risk Management - The company acknowledges that financial market conditions can significantly impact investment returns, and it will adjust its investment strategy based on economic conditions [13]. - Measures will be taken to strengthen internal control management and ensure compliance with relevant regulations to mitigate investment risks [15][16]. Group 4: Impact on Company Operations - The entrusted wealth management will not affect the company's normal operations or main business activities, and it is expected to enhance the efficiency of idle fund utilization [18].

Core Viewpoint - Shandong Weida Machinery Co., Ltd. has announced several key decisions during its board meeting on December 30, 2025, including planned related party transactions and financial strategies for 2026 [1][2][3]. Trading Information Summary - As of December 31, 2025, Shandong Weida's stock closed at 15.05 yuan, down 0.46%, with a turnover rate of 4.62%, trading volume of 195,400 hands, and a transaction amount of 295 million yuan [1]. - On the same day, the net outflow of main funds was 22.903 million yuan, accounting for 7.76% of the total transaction amount, while retail investors saw a net inflow of 23.907 million yuan, representing 8.1% of the total [1][4]. Company Announcements Summary - The board approved expected related party transactions for 2026 with Shandong Weida Group and its subsidiaries, estimating a total amount not exceeding 13.692 million yuan for procurement, labor services, and leasing [1][2]. - The company plans to conduct foreign exchange forward settlement and swap transactions from January 1, 2026, to December 31, 2026, with amounts not exceeding 150 million USD and 10 million USD, respectively [2][3]. - The company intends to use up to 1.3 billion yuan of idle funds for entrusted wealth management throughout 2026, aiming for higher efficiency and returns than bank deposit rates [4][5]. Financial Management and Control - The company has established internal control measures for foreign exchange risk management, ensuring that transactions are conducted with qualified financial institutions and are not speculative [3][17]. - A comprehensive internal reporting system for significant information has been implemented, requiring timely reporting of major transactions and related party dealings to the board [6]. - The company has set up a wealth management system to regulate the use of idle funds, emphasizing risk prevention and prudent investment practices [16].

关于召开2026年第一次临时股东会的通知 南方风机股份有限公司将于2026年1月16日召开2026年第一次临时股东会，会议由董事会召集，采用现 场表决与网络投票相结合方式。股权登记日为2026年1月12日。会议审议《关于母公司及子公司使用公 积金弥补亏损的议案》，对中小投资者表决情况单独计票。现场会议地点为广东省佛山市南海区小塘三 环西路31号公司一楼会议室。网络投票通过深交所交易系统和互联网投票系统进行。登记时间为2026年 1月15日，可通过现场、信函或传真方式登记。 截至2025年12月31日收盘，南风股份(300004)报收于12.25元，上涨4.7%，换手率9.29%，成交量44.61万 手，成交额5.39亿元。 当日关注点 交易信息汇总资金流向 12月31日主力资金净流出4549.8万元，占总成交额8.44%；游资资金净流入2413.66万元，占总成交额 4.48%；散户资金净流入2136.14万元，占总成交额3.96%。 公司公告汇总第六届董事会第十二次会议决议公告 南方风机股份有限公司于2025年12月30日召开第六届董事会第十二次会议，审议通过《关于2026年度使 用自有资金进行委托理财的议 ...

Core Viewpoint - Shandong Weida (002026) has reported a slight increase in stock price and has outlined its plans for 2026, including various financial transactions and associated risks management strategies [1][2]. Company Announcements - The 6th temporary meeting of the 10th Board of Directors was held on December 30, 2025, where several key resolutions were passed, including expected daily related transactions for 2026 with Shandong Weida Rem Machinery Co., Ltd. and Shandong Weida Group Co., Ltd. totaling no more than 13.69 million yuan [1][3]. - The company plans to conduct foreign exchange forward settlement and swap transactions with amounts not exceeding 150 million USD and 10 million USD, respectively, to mitigate foreign exchange risk [2][3]. - The company intends to use up to 1.3 billion yuan of idle funds for entrusted wealth management, with a focus on low-risk, stable financial products for the period from January 1, 2026, to December 31, 2026 [2][3]. Related Transactions - For the fiscal year 2026, the company anticipates related transactions with Shandong Weida Rem Machinery Co., Ltd. involving sales and services not exceeding 30 million yuan and purchases not exceeding 60 million yuan, along with rental of factory space not exceeding 700,000 yuan [2][3]. - The pricing for these related transactions will adhere to market principles and has been approved by the Board of Directors, with related directors abstaining from voting [2][3].